AmeriSource Decision a Difficult Pill to Swallow for Securities Plaintiffs
The opioid crisis has garnered nationwide attention for decades and has resulted in thousands of lawsuits, subjecting pharmaceutical distributors to billions of dollars in damages. AmerisourceBergen (“Amerisource”) — one of the “big three” largest pharmaceutical distributors in the U.S. — has frequently been accused of failing to adequately monitor and report suspicious orders of prescription…
Read more